Thrivent Financial for Lutherans’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-11,991
Closed -$666K 2482
2021
Q2
$666K Sell
11,991
-214,131
-95% -$11.4M ﹤0.01% 2077
2021
Q1
$10.6M Sell
226,122
-8,143
-3% -$394K 0.02% 643
2020
Q4
$10.2M Buy
234,265
+2,867
+1% +$106K 0.02% 641
2020
Q3
$8.47M Sell
231,398
-6,516
-3% -$221K 0.02% 644
2020
Q2
$6.94M Buy
+237,914
New +$6.57M 0.02% 635

Other funds holding HCAT

Thrivent Financial for Lutherans's HCAT Position: Q3 2021 in Review

Thrivent Financial for Lutherans sold out of Health Catalyst (HCAT) in Q3 2021, closing a stake of 11,991 shares — an estimated $666K sold.

Thrivent Financial for Lutherans first reported a position in HCAT in Q2 2020 and held it in 5 quarters. The position peaked at $10.6M in Q1 2021. 198 funds tracked by Wall St. Rank hold HCAT as of Q3 2021.

  • Thrivent Financial for Lutherans reported no remaining Health Catalyst position as of Q3 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 11,991 Health Catalyst shares in Q3 2021, an estimated $666K.
  • Thrivent Financial for Lutherans first reported a position in Health Catalyst in Q2 2020 and held it in 5 quarters.
  • Thrivent Financial for Lutherans's Health Catalyst position peaked at $10.6M in Q1 2021.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2021, filed 15 Nov 2021.